<DOC>
	<DOCNO>NCT01055145</DOCNO>
	<brief_summary>Fluoroquinolone one important drug treatment multidrug-resistant TB ( MDR-TB ) . Among , levofloxacin moxifloxacin use widely . However , study directly compare efficacy levofloxacin moxifloxacin among MDR-TB patient . The investigator compare efficacy levofloxacin moxifloxacin prospective multicenter randomize open label phase III trial .</brief_summary>
	<brief_title>Comparison Effect Between Levofloxacin Moxifloxacin Among MDR-TB Patients</brief_title>
	<detailed_description />
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Patients multidrugresistant TB , sensitive levofloxacin moxifloxacin Achieved negative conversion M. TB culture enrollment Positive antiHIV antibody Pregnant woman sexually active woman without use proper birth control method Serum creatine grater 2mg/dL , urine protein great 2+ Serum total bilirubin great 2 mg/dL AST ALT great 1.5 time normal upper limit History current arrhythmia Hypersensitivity levofloxacin , moxifloxacin , rifabutin Should use drug contain metalion , warfarin , phenytoin , theophylline , probenecid regularly</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Multidrug-resistant TB , sensitive levofloxacin moxifloxacin</keyword>
</DOC>